← Back to Search

Behavioral Exposure Therapy for Exercise Intolerance (BE-FIT Trial)

Phase 2
Recruiting
Research Sponsored by Rutgers, The State University of New Jersey
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Medically approved cardiac rehabilitation
≥ 40 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

BE-FIT Trial Summary

This trial is testing a mechanism-informed behavioral intervention, BE-FIT, to target exercise anxiety in order to increase exercise outcomes. The intervention includes exposure to feared bodily sensations and exercise, prevention of safety behavior use, and use of a wrist-worn activity monitor for feedback and goal setting.

Who is the study for?
This trial is for individuals over 40 with high exercise anxiety, approved for cardiac rehab, and not very active. They must speak English and have no severe cognitive impairments or chronic conditions that could interfere with the study.Check my eligibility
What is being tested?
The BE-FIT program aims to reduce exercise anxiety through exposure therapy, stopping safety behaviors around exercise, and using a wrist activity monitor. It's being compared to standard health education in a randomized-controlled trial.See study design
What are the potential side effects?
There are no specific side effects mentioned for BE-FIT; however, as it involves physical activity and exposure therapy, participants may initially experience increased anxiety or discomfort during exercises.

BE-FIT Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am enrolled in a heart health rehab program.
Select...
I am 40 years old or older.

BE-FIT Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Overall minutes of exercise
Secondary outcome measures
Objectively measured Lifestyle PA (steps/day).
Percent of prescribed cardiac rehabilitation attended.

BE-FIT Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Behavioral Exposure For Introceptive ToleranceExperimental Treatment1 Intervention
The BE-FIT intervention is a cognitive-behavioral intervention and is designed to target exercise anxiety. The three main components of BE-FIT include: 1) exposure to feared bodily sensations and exercise, 2) prevention of safety behavior use before/during/after exercise, and 3) use of a wrist-worn activity monitor (Fitbit) for PA feedback and activity goal setting.
Group II: Health Education ControlActive Control1 Intervention
HEC is a time-matched control intervention that will be delivered on the same delivery schedule as BE-FIT. In this arm, participants will be provided educational information about health topics relevant to healthy aging delivered through PowerPoint lectures and handouts and use a Fitbit for PA monitoring.

Find a Location

Who is running the clinical trial?

Rutgers, The State University of New JerseyLead Sponsor
429 Previous Clinical Trials
64,086 Total Patients Enrolled
7 Trials studying Anxiety
1,423 Patients Enrolled for Anxiety
National Institute on Aging (NIA)NIH
1,674 Previous Clinical Trials
28,020,759 Total Patients Enrolled
12 Trials studying Anxiety
2,641 Patients Enrolled for Anxiety

Media Library

Behavioral Exposure For Introceptive Tolerance Clinical Trial Eligibility Overview. Trial Name: NCT05398276 — Phase 2
Anxiety Research Study Groups: Behavioral Exposure For Introceptive Tolerance, Health Education Control
Anxiety Clinical Trial 2023: Behavioral Exposure For Introceptive Tolerance Highlights & Side Effects. Trial Name: NCT05398276 — Phase 2
Behavioral Exposure For Introceptive Tolerance 2023 Treatment Timeline for Medical Study. Trial Name: NCT05398276 — Phase 2
Anxiety Patient Testimony for trial: Trial Name: NCT05398276 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What potential risks are associated with Behavioral Exposure For Introceptive Tolerance?

"Our team at Power assigned Behavioral Exposure For Introceptive Tolerance a score of 2 following our evaluation, as this is currently in the Phase 2 trial stage and has limited data supporting its safety but none proving efficacy."

Answered by AI

What is the uppermost cap on participants of this research trial?

"Affirmative. Clinicaltrials.gov states that this experiment is currently looking for participants, which was first listed on May 3rd 2022 and recently edited on the 26th of May. The study requires 146 subjects to be recruited between 2 distinct sites."

Answered by AI

Are there any openings for individuals to join this clinical trial?

"Correct. Per the information hosted on clinicaltrials.gov, this medical trial is recruiting participants with a start date of May 3rd 2022 and an update from May 26th 2022. 146 individuals need to be recruited across two sites for the study's success."

Answered by AI

Who else is applying?

What state do they live in?
New Jersey
Missouri
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
3+
What site did they apply to?
RWJ Cardiac Rehab at East Brunswick
Rutgers Emotion, Health and Behavior Laboratory Department of Psychology

Why did patients apply to this trial?

I'm tired of dealing with anxiety I'm 53 years old I've been dealing with it all my life and it just seems to be getting worse.
PatientReceived 2+ prior treatments
~79 spots leftby Jul 2026